🗞
Medical News ⚠️
Safety alertNovartis Pharma Schweiz AG has notified the Ethiopian Food and Drug Authority (EFDA) that Tegretol® (carbamazepine) 100 mg/5ml Oral Suspension should no longer be used for neonates (below 4 weeks for term babies or 44 weeks post-menstrual age for pre-term babies) due to the
propylene glycol (PG) content, which exceeds safe limits for this age group.
The EFDA advises health professionals to
avoid prescribing or dispensing this medication to neonates, as the risks outweigh the benefits.
@HakimApps_Guideline